Tikun Olam-Cannbit Pharmaceuticals Ltd. logo

Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUNF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
6. 00
0
0%
$
- Market Cap
- P/E Ratio
5,645,387.6% Div Yield
0 Volume
0 Eps
$ 6
Previous Close
Add Transaction
Day Range
6 6
Year Range
0.06 6
Want to track TKUNF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TKUNF closed Friday higher at $6, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, TKUNF stock gained 9,900.0002%.
TKUNF is not paying dividends to its shareholders.
The last earnings report, released on Feb 13, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Tikun Olam-Cannbit Pharmaceuticals Ltd. has completed 1 stock splits, with the recent split occurring on Mar 02, 2026.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on TASE (ILA).

TKUNF Chart

Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUNF) FAQ

What is the stock price today?

The current price is $6.00.

On which exchange is it traded?

Tikun Olam-Cannbit Pharmaceuticals Ltd. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is TKUNF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 5.65M%.

What is its market cap?

As of today, no market cap data is available.

Has Tikun Olam-Cannbit Pharmaceuticals Ltd. ever had a stock split?

Tikun Olam-Cannbit Pharmaceuticals Ltd. had 1 splits and the recent split was on Mar 02, 2026.

Tikun Olam-Cannbit Pharmaceuticals Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Ronen Elad CEO
OTC PINK Exchange
IL0010843675 ISIN
Israel Country
19 Employees
28 Dec 2011 Last Dividend
2 Mar 2026 Last Split
- IPO Date

Overview

Tikun Olam-Cannbit Pharmaceuticals Ltd is a dynamic player in the field of medical cannabis, focusing on the cultivation, production, marketing, storage, distribution, export, and import, as well as the sale of cannabis-based products. With its foundation deeply rooted in Israel, specifically in Nof HaGalil, the company stands out for its dedication to leveraging the therapeutic potentials of cannabis. Its operations are tailored towards harnessing the medical benefits of cannabis to address a broad spectrum of medical indications, thereby contributing significantly to the evolving landscape of medical cannabis research and application. Beyond its product offerings, Tikun Olam-Cannbit extends its services to encompass training and patient care, indicating its commitment to not only pioneering innovations in medical cannabis but also ensuring patients derive the maximum benefit from their treatments.

Products and Services

  • Medical Cannabis Products:

    At the core of Tikun Olam-Cannbit Pharmaceuticals’ offerings are its medical cannabis products. These are meticulously developed for the treatment and relief of symptoms across a wide array of medical indications. The company’s products stand out for their quality and efficacy, providing patients with alternative treatment options that leverage the therapeutic benefits of cannabis.

  • Training:

    Recognizing the importance of education in maximizing the benefits of medical cannabis, Tikun Olam-Cannbit offers comprehensive training programs. These initiatives are designed to enlighten healthcare providers about the nuances of medical cannabis, from its therapeutic applications to the best practices in its administration. This ensures that practitioners are well-equipped to guide their patients in the effective use of cannabis-based treatments.

  • Patient Care Services:

    A testament to its patient-centric approach, Tikun Olam-Cannbit provides exemplary patient care services. This facet of the company’s offerings denotes its commitment to supporting patients throughout their treatment journey. From consultation and prescription to follow-up care, the company ensures that patients receive personalized care and guidance tailored to their specific needs and medical conditions.

Contact Information

Address: Hitad 2
Phone: 972 4 657 5522